ReviewBiomedicines2022
Immunotherapy for SMARCB1-Deficient Sarcomas: Current Evidence and Future Developments.
Carine Ngo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it
ReviewBiomedicines2022
Carine Ngo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.